Stem Cell Research in MS
Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing HSCT with existing treatments in relapsing and progressive MS.
New Light on the Pathogenesis of MS
How MS develops continues to be an area of considerable interest and research. This month’s ECTRIMS Insight sheds new light on the pathogenesis of MS
NEW! ECTRIMS NeuroWebinar
This year’s first NeuroWebinar on 26 Jan 16:00 CET explores the newly proposed “mechanism-driven” framework for describing MS, moving away from purely clinical descriptions.
